Consequently, the authors concluded that [99mTc]Tc-PSMA-I&S could be used for primary staging and for restaging of advanced recurrent PCa only if PSA levels are greater than 4 ng/mL. The gene discussed is KLK3; the disease is posterior cortical atrophy.